Solidarity for Hepatitis Elimination: A Call for a UN Group of Friends
Details
- September 20, 2022
-
10:00 am - 1:00 pm EDT
- Issues:
- GovernmentHealth
Add to Calendar
September 20, 2022 10:00 am
September 20, 2022 1:00 pm
America/New_York
Solidarity for Hepatitis Elimination: A Call for a UN Group of Friends
The Task Force for Global Health, an official non-state actor of WHO, invites you to join this multinational event on Solidarity for Hepatitis Elimination. The event will entail participation from Ministers of Health, Foreign Affairs Ministers, UN Mission Representatives, and other stakeholders from various countries. Dignitaries are also preparing remarks in video as part of a video exhibition. The designated dignitaries shall give remarks regarding the advancements in health from their national hepatitis C programs and how diplomatic cooperation at the international level can accelerate efforts to eliminate hepatitis by 2030.
The event will initiate the discussion on launching the Group of Friends for Hepatitis Elimination at the United Nations that will be a tool to actively engage Member States and advance progress toward hepatitis elimination. The quorum will explore together the formation of a Group of Friends for Hepatitis Elimination.
Why the Group of Friends for Hepatitis Elimination is needed
Hepatitis is a global health threat. In 2015, WHO reported hepatitis B virus (HBV) and hepatitis C virus (HCV) caused over 10 million new infections and 300 million chronic infections, leading to 1.3 million deaths annually from liver disease and liver cancer (iii). In response, the United Nations (in the Sustainable Development Goals) called on the world to combat viral hepatitis. In 2016, WHO released global strategies, endorsed by all Member States of the World Health Assembly, to guide delivery of hepatitis B vaccination, testing and care services to treat hepatitis B and cure hepatitis C infection to reach the goals for hepatitis elimination i.e., 90% reduction in new infections and 65% reduction in deaths by 2030. The WHO global strategy guides Member States development of hepatitis elimination programs.
Hepatitis is a global health threat. In 2015, WHO reported hepatitis B virus (HBV) and hepatitis C virus (HCV) caused over 10 million new infections and 300 million chronic infections, leading to 1.3 million deaths annually from liver disease and liver cancer (iii). In response, the United Nations (in the Sustainable Development Goals) called on the world to combat viral hepatitis. In 2016, WHO released global strategies, endorsed by all Member States of the World Health Assembly, to guide delivery of hepatitis B vaccination, testing and care services to treat hepatitis B and cure hepatitis C infection to reach the goals for hepatitis elimination i.e., 90% reduction in new infections and 65% reduction in deaths by 2030. The WHO global strategy guides Member States development of hepatitis elimination programs.
Member States have made substantial progress toward hepatitis elimination goals. However, major inequities exist in access to hepatitis prevention, testing and treatment. Indeed, the world achieved the interim UN Sustainable Development Goal (SDG) of reducing global hepatitis B prevalence to <1% among young children through vaccination, placing many countries on track to achieve the final SDG goal of < 0.1% HBV prevalence by 2030. However, this interim goal has yet to be achieved in the WHO African region. As a result of low vaccination coverage, 1 in 40 African children are infected with HBV, a prevalence almost three-fold greater than the goal achieved globally. Model
countries scaled up broad access to hepatitis C testing and curative therapies demonstrating the feasibility of hepatitis C elimination. With awareness of the benefits and feasibility of hepatitis elimination, other countries are in various stages of developing programs for hepatitis C
elimination. Assistance from international sources catalyze nations’ efforts to eliminate hepatitis. Globally, of the ~ 350 million persons living with hepatitis B or hepatitis C, < 20% are aware of their infection and < 10% have received treatment.
countries scaled up broad access to hepatitis C testing and curative therapies demonstrating the feasibility of hepatitis C elimination. With awareness of the benefits and feasibility of hepatitis elimination, other countries are in various stages of developing programs for hepatitis C
elimination. Assistance from international sources catalyze nations’ efforts to eliminate hepatitis. Globally, of the ~ 350 million persons living with hepatitis B or hepatitis C, < 20% are aware of their infection and < 10% have received treatment.
A Group of Friends for Hepatitis Elimination can bring Member States together for Diplomatic Cooperation
Multilateral collaborations can advance equitable access to health services for the elimination of hepatitis. Member States now convene a Group of Friends promoting advancements on a variety of specific issues and causes. A Group of Friends for Hepatitis Elimination provides a forum for information exchange on progress, innovations and lessons learned among Member States, UN organizations and other stakeholders. Through collective influence, the Group of Friends can convene UN special events, develop UN resolutions and other calls for action. By raising awareness at the diplomatic level, the UN Group of Friends for Hepatitis Elimination can bring high-level attention of donor agencies, development banks, philanthropic donors and national governments helping low- middle income countries (LMICs) eliminate hepatitis. As the world moves from pandemic response to pandemic recovery, the Group of Friends can open additional channels of
dialogue and collaboration at the diplomatic level to advance progress toward universal health coverage reducing disparities in services preventing hepatitis virus transmission and disease.
Multilateral collaborations can advance equitable access to health services for the elimination of hepatitis. Member States now convene a Group of Friends promoting advancements on a variety of specific issues and causes. A Group of Friends for Hepatitis Elimination provides a forum for information exchange on progress, innovations and lessons learned among Member States, UN organizations and other stakeholders. Through collective influence, the Group of Friends can convene UN special events, develop UN resolutions and other calls for action. By raising awareness at the diplomatic level, the UN Group of Friends for Hepatitis Elimination can bring high-level attention of donor agencies, development banks, philanthropic donors and national governments helping low- middle income countries (LMICs) eliminate hepatitis. As the world moves from pandemic response to pandemic recovery, the Group of Friends can open additional channels of
dialogue and collaboration at the diplomatic level to advance progress toward universal health coverage reducing disparities in services preventing hepatitis virus transmission and disease.
TFGH is coordinating this event with the WHO office in New York and the WHO Global HIV, Hepatitis and STI Programme. TFGH activities are supported by the general fund. There are no industry sponsors for this event.
About Task Force for Global Health
The Task Force for Global Health was founded in Atlanta nearly 40 years ago to advance health equity. The TFGH is an official non –state actor of WHO with programs working with local partners in > 150 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. The Coalition for Global Hepatitis Elimination provides services to assist the planning, implementation, and evaluation of national and subnational programs to prevent hepatitis B virus and hepatitis C virus transmission and disease accelerating progress toward global goals for hepatitis elimination.
Location of the event
The Task Force for Global Health was founded in Atlanta nearly 40 years ago to advance health equity. The TFGH is an official non –state actor of WHO with programs working with local partners in > 150 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. The Coalition for Global Hepatitis Elimination provides services to assist the planning, implementation, and evaluation of national and subnational programs to prevent hepatitis B virus and hepatitis C virus transmission and disease accelerating progress toward global goals for hepatitis elimination.
The Task Force for Global Health, an official non-state actor of WHO, invites you to join this multinational event on Solidarity for Hepatitis Elimination. The event will entail participation from Ministers of Health, Foreign Affairs Ministers, UN Mission Representatives, and other stakeholders from various countries. Dignitaries are also preparing remarks in video as part of a video exhibition. The designated dignitaries shall give remarks regarding the advancements in health from their national hepatitis C programs and how diplomatic cooperation at the international level can accelerate efforts to eliminate hepatitis by 2030.
The event will initiate the discussion on launching the Group of Friends for Hepatitis Elimination at the United Nations that will be a tool to actively engage Member States and advance progress toward hepatitis elimination. The quorum will explore together the formation of a Group of Friends for Hepatitis Elimination.
Why the Group of Friends for Hepatitis Elimination is needed
Hepatitis is a global health threat. In 2015, WHO reported hepatitis B virus (HBV) and hepatitis C virus (HCV) caused over 10 million new infections and 300 million chronic infections, leading to 1.3 million deaths annually from liver disease and liver cancer (iii). In response, the United Nations (in the Sustainable Development Goals) called on the world to combat viral hepatitis. In 2016, WHO released global strategies, endorsed by all Member States of the World Health Assembly, to guide delivery of hepatitis B vaccination, testing and care services to treat hepatitis B and cure hepatitis C infection to reach the goals for hepatitis elimination i.e., 90% reduction in new infections and 65% reduction in deaths by 2030. The WHO global strategy guides Member States development of hepatitis elimination programs.
Hepatitis is a global health threat. In 2015, WHO reported hepatitis B virus (HBV) and hepatitis C virus (HCV) caused over 10 million new infections and 300 million chronic infections, leading to 1.3 million deaths annually from liver disease and liver cancer (iii). In response, the United Nations (in the Sustainable Development Goals) called on the world to combat viral hepatitis. In 2016, WHO released global strategies, endorsed by all Member States of the World Health Assembly, to guide delivery of hepatitis B vaccination, testing and care services to treat hepatitis B and cure hepatitis C infection to reach the goals for hepatitis elimination i.e., 90% reduction in new infections and 65% reduction in deaths by 2030. The WHO global strategy guides Member States development of hepatitis elimination programs.
Member States have made substantial progress toward hepatitis elimination goals. However, major inequities exist in access to hepatitis prevention, testing and treatment. Indeed, the world achieved the interim UN Sustainable Development Goal (SDG) of reducing global hepatitis B prevalence to <1% among young children through vaccination, placing many countries on track to achieve the final SDG goal of < 0.1% HBV prevalence by 2030. However, this interim goal has yet to be achieved in the WHO African region. As a result of low vaccination coverage, 1 in 40 African children are infected with HBV, a prevalence almost three-fold greater than the goal achieved globally. Model
countries scaled up broad access to hepatitis C testing and curative therapies demonstrating the feasibility of hepatitis C elimination. With awareness of the benefits and feasibility of hepatitis elimination, other countries are in various stages of developing programs for hepatitis C
elimination. Assistance from international sources catalyze nations’ efforts to eliminate hepatitis. Globally, of the ~ 350 million persons living with hepatitis B or hepatitis C, < 20% are aware of their infection and < 10% have received treatment.
countries scaled up broad access to hepatitis C testing and curative therapies demonstrating the feasibility of hepatitis C elimination. With awareness of the benefits and feasibility of hepatitis elimination, other countries are in various stages of developing programs for hepatitis C
elimination. Assistance from international sources catalyze nations’ efforts to eliminate hepatitis. Globally, of the ~ 350 million persons living with hepatitis B or hepatitis C, < 20% are aware of their infection and < 10% have received treatment.
A Group of Friends for Hepatitis Elimination can bring Member States together for Diplomatic Cooperation
Multilateral collaborations can advance equitable access to health services for the elimination of hepatitis. Member States now convene a Group of Friends promoting advancements on a variety of specific issues and causes. A Group of Friends for Hepatitis Elimination provides a forum for information exchange on progress, innovations and lessons learned among Member States, UN organizations and other stakeholders. Through collective influence, the Group of Friends can convene UN special events, develop UN resolutions and other calls for action. By raising awareness at the diplomatic level, the UN Group of Friends for Hepatitis Elimination can bring high-level attention of donor agencies, development banks, philanthropic donors and national governments helping low- middle income countries (LMICs) eliminate hepatitis. As the world moves from pandemic response to pandemic recovery, the Group of Friends can open additional channels of
dialogue and collaboration at the diplomatic level to advance progress toward universal health coverage reducing disparities in services preventing hepatitis virus transmission and disease.
Multilateral collaborations can advance equitable access to health services for the elimination of hepatitis. Member States now convene a Group of Friends promoting advancements on a variety of specific issues and causes. A Group of Friends for Hepatitis Elimination provides a forum for information exchange on progress, innovations and lessons learned among Member States, UN organizations and other stakeholders. Through collective influence, the Group of Friends can convene UN special events, develop UN resolutions and other calls for action. By raising awareness at the diplomatic level, the UN Group of Friends for Hepatitis Elimination can bring high-level attention of donor agencies, development banks, philanthropic donors and national governments helping low- middle income countries (LMICs) eliminate hepatitis. As the world moves from pandemic response to pandemic recovery, the Group of Friends can open additional channels of
dialogue and collaboration at the diplomatic level to advance progress toward universal health coverage reducing disparities in services preventing hepatitis virus transmission and disease.
TFGH is coordinating this event with the WHO office in New York and the WHO Global HIV, Hepatitis and STI Programme. TFGH activities are supported by the general fund. There are no industry sponsors for this event.
About Task Force for Global Health
The Task Force for Global Health was founded in Atlanta nearly 40 years ago to advance health equity. The TFGH is an official non –state actor of WHO with programs working with local partners in > 150 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. The Coalition for Global Hepatitis Elimination provides services to assist the planning, implementation, and evaluation of national and subnational programs to prevent hepatitis B virus and hepatitis C virus transmission and disease accelerating progress toward global goals for hepatitis elimination.
The Task Force for Global Health was founded in Atlanta nearly 40 years ago to advance health equity. The TFGH is an official non –state actor of WHO with programs working with local partners in > 150 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. The Coalition for Global Hepatitis Elimination provides services to assist the planning, implementation, and evaluation of national and subnational programs to prevent hepatitis B virus and hepatitis C virus transmission and disease accelerating progress toward global goals for hepatitis elimination.